RETRACTED ARTICLE: Silencing SP1 Alleviated Sevoflurane-Induced POCD Development via Cholinergic Anti-inflammatory Pathway

Guoying Lv, Chuangang Li, Weiwei Wang, Ning Li, Kai Wang

Open source

DOI
10.1007/s11064-020-03070-7
Published
2020-06-27
Container
Neurochemical Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11064-020-03070-7,
  title = {RETRACTED ARTICLE: Silencing SP1 Alleviated Sevoflurane-Induced POCD Development via Cholinergic Anti-inflammatory Pathway},
  author = {Guoying Lv and Chuangang Li and Weiwei Wang and Ning Li and Kai Wang},
  year = {2020},
  journal = {Neurochemical Research},
  doi = {10.1007/s11064-020-03070-7},
  url = {https://doi.org/10.1007/s11064-020-03070-7}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: Silencing SP1 Alleviated Sevoflurane-Induced POCD Development via Cholinergic Anti-inflammatory Pathway
AU  - Guoying Lv
AU  - Chuangang Li
AU  - Weiwei Wang
AU  - Ning Li
AU  - Kai Wang
PY  - 2020
JO  - Neurochemical Research
DO  - 10.1007/s11064-020-03070-7
UR  - https://doi.org/10.1007/s11064-020-03070-7
ER  - 

APA

Lv, G., Li, C., Wang, W., Li, N., & Wang, K. (2020). RETRACTED ARTICLE: Silencing SP1 Alleviated Sevoflurane-Induced POCD Development via Cholinergic Anti-inflammatory Pathway. Neurochemical Research. https://doi.org/10.1007/s11064-020-03070-7

Source records